Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Companies share secrets to reduce unforeseen phase I problems

April 26, 2006 Research and Development

Eight of the industry's leading companies have begun work on a unique new project to help overcome one of the …
News

UK pharma industry unites to take the Code to customers

April 26, 2006 Research and Development

Companies from across the UK pharma industry have come together in an unprecedented campaign to promote awareness of its code …
News

Pfizer vows to fight ‘perverse and short-sighted decision’ on Exubera

April 24, 2006 Research and Development

Exubera, the world's first inhaled insulin, has failed to gain NICE approval after manufacturer Pfizer couldnt convince the Institute of …
News

GSK unveils first of new virtual pipeline drug discovery alliances

April 24, 2006 Research and Development

Pharmacopeia, a small New Jersey pharmaceutical company will be the first to enter into a new kind of drug development …
News

Wyeth to collaborate with Scottish universities on biomarkers

April 11, 2006 Research and Development

 Wyeth is to invest $86 million in a new collaboration with Scotland's leading medical researchers in a cutting edge area …
News

Fears for UK clinical trials as antibody inquiry proceeds

April 10, 2006 Research and Development

The MHRA is to put together an expert group to examine the need for new safety measures in the wake …
News

Lyrica to challenge antidepressants with new anxiety disorder approval

April 7, 2006 Research and Development

Pfizer's Lyrica is to go head to head with top-selling antidepressant drugs as it enters the market to treat generalised …
News

Novartis launch innovative leukaemia awareness campaign

March 30, 2006 Research and Development

Novartis has launched an innovative new campaign to raise awareness of leukaemia treatment among the UK's general practitioners; a move …
News

Novartis to develop Servier’s antidepressant for US

March 30, 2006 Research and Development

Novartis has signed a deal to develop and market Servier's new antidepressant and agomelatine for the US market.The drug has …
News

Novartis targets China with hepatitis drug

March 30, 2006 Research and Development

Novartis says trials of its new hepatitis drug in Chinese patients show it to be superior to standard treatment, in …
News

Taxotere approved for stomach cancer in US

March 28, 2006 Research and Development

Sanofi-Aventis has won US approval to market its drug Taxotere as a treatment for stomach cancer, and says it is …
News

Row over cardiovascular targets in new GP contract

March 24, 2006 Research and Development

Patient groups have condemned the new GP contract, saying it ignores a potentially life-threatening condition in tens of thousands of …
News

Investigators to examine Northwick Park trial safety

March 16, 2006 Research and Development

Two men involved in a UK clinical trial of new anti-inflammatory drug remain in a critical condition more than three …
News

World’s biggest DNA project launched

March 16, 2006 Research and Development DNA, MRC, UK Biobank, Wellcome

UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …
News

Deaths reported in dementia trial

March 16, 2006 Research and Development

Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026